2503 ORAL Erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): results from a randomized phase II trial (EORTC 26034)
- 30 September 2007
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 5 (4) , 228
- https://doi.org/10.1016/s1359-6349(07)70906-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: